Reckitt Benckiser Group PLC

RKT: XLON (GBR)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|NhLOCK|<c>LOCK|##>SSd<

Reckitt Benckiser: Weak Flu Season and Geopolitical Issues in Emerging Markets Weigh on Sales

Reckitt reported modest 0.6% like-for-like sales growth in the first quarter, with the core portfolio up 1.3%, below the company-compiled consensus and substantially decelerating sequentially, however, 2026 guidance was confirmed. Shares fell 6% intraday on April 22.

Sponsor Center